Empiric Guideline-Recommended Weight-Based Vancomycin Dosing and Mortality in Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Retrospective Cohort Study
dc.contributor.utaustinauthor | Frei, Chistopher R. | en_US |
dc.contributor.utaustinauthor | Forcade, Nicolas A. | en_US |
dc.creator | Hall, Ronald G., II | en_US |
dc.creator | Giuliano, Christopher A. | en_US |
dc.creator | Haase, Krystal K. | en_US |
dc.creator | Hazlewood, Kathleen A. | en_US |
dc.creator | Frei, Chistopher R. | en_US |
dc.creator | Forcade, Nicolas A. | en_US |
dc.creator | Brouse, Sara D. | en_US |
dc.creator | Bell, Todd | en_US |
dc.creator | Bedimo, Roger J. | en_US |
dc.creator | Alvarez, Carlos A. | en_US |
dc.date.accessioned | 2016-10-28T19:49:15Z | |
dc.date.available | 2016-10-28T19:49:15Z | |
dc.date.issued | 2012-04 | en_US |
dc.description.abstract | No studies have evaluated the effect of guideline-recommended weight-based dosing on in-hospital mortality of patients with methicillin-resistant Staphylococcus aureus bacteremia. Methods: This was a multicenter, retrospective, cohort study of patients with methicillin-resistant Staphylococcus aureus bacteremia receiving at least 48 hours of empiric vancomycin therapy between 01/07/2002 and 30/06/2008. We compared in-hospital mortality for patients treated empirically with weight-based, guideline-recommended vancomycin doses (at least 15 mg/kg/dose) to those treated with less than 15 mg/kg/dose. We used a general linear mixed multivariable model analysis with variables identified a priori through a conceptual framework based on the literature. Results: A total of 337 patients who were admitted to the three hospitals were included in the cohort. One-third of patients received vancomycin empirically at the guideline-recommended dose. Guideline-recommended dosing was not associated with in-hospital mortality in the univariable (16% vs. 13%, OR 1.26 [95% CI 0.67-2.39]) or multivariable (OR 0.71, 95% CI 0.33-1.55) analysis. Independent predictors of in-hospital mortality were ICU admission, Pitt bacteremia score of 4 or greater, age 53 years or greater, and nephrotoxicity. Conclusions: Empiric use of weight-based, guideline-recommended empiric vancomycin dosing was not associated with reduced mortality in this multicenter study. | en_US |
dc.description.department | Pharmaceutical Sciences | en_US |
dc.description.sponsorship | North and Central Texas Clinical and Translational Science Initiative from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) KL2RR024983 | en_US |
dc.description.sponsorship | NIH Roadmap for Medical Research | en_US |
dc.description.sponsorship | NIH grant KL2RR025766 | en_US |
dc.identifier | doi:10.15781/T2ST7F06D | |
dc.identifier.citation | Hall, Ronald G., Christopher A. Giuliano, Krystal K. Haase, Kathleen A. Hazlewood, Chistopher R. Frei, Nicolas A. Forcade, Sara D. Brouse, Todd Bell, Roger J. Bedimo, and Carlos A. Alvarez. "Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study." BMC infectious diseases, Vol. 12, No. 1 (Apr., 2012): 1. | en_US |
dc.identifier.doi | 10.1186/1471-2334-12-104 | en_US |
dc.identifier.issn | 1471-2334 | en_US |
dc.identifier.uri | http://hdl.handle.net/2152/43139 | |
dc.language.iso | English | en_US |
dc.relation.ispartof | en_US | |
dc.relation.ispartofserial | BMC Infectious Diseases | en_US |
dc.rights | Administrative deposit of works to Texas ScholarWorks: This works author(s) is or was a University faculty member, student or staff member; this article is already available through open access or the publisher allows a PDF version of the article to be freely posted online. The library makes the deposit as a matter of fair use (for scholarly, educational, and research purposes), and to preserve the work and further secure public access to the works of the University. | en_US |
dc.rights.restriction | Open | en_US |
dc.subject | weight | en_US |
dc.subject | obesity | en_US |
dc.subject | efficacy | en_US |
dc.subject | mrsa | en_US |
dc.subject | vancomycin | en_US |
dc.subject | bacteremia | en_US |
dc.subject | therapy | en_US |
dc.subject | pharmacokinetics | en_US |
dc.subject | prediction | en_US |
dc.subject | infectious diseases | en_US |
dc.title | Empiric Guideline-Recommended Weight-Based Vancomycin Dosing and Mortality in Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Retrospective Cohort Study | en_US |
dc.type | Article | en_US |